154 related articles for article (PubMed ID: 7019707)
1. Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin.
Freidenberg GR; White N; Cataland S; O'Dorisio TM; Sotos JF; Santiago JV
N Engl J Med; 1981 Aug; 305(7):363-8. PubMed ID: 7019707
[TBL] [Abstract][Full Text] [Related]
2. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy.
White NH; Skor DA; Cryer PE; Levandoski LA; Bier DM; Santiago JV
N Engl J Med; 1983 Mar; 308(9):485-91. PubMed ID: 6337335
[TBL] [Abstract][Full Text] [Related]
3. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous insulin resistance syndrome. Effects of long-term aprotinin therapy.
Guillausseau PJ; Guillausseau C; Boucheteil P; Lubetzki J
Diabetes Res; 1986 Sep; 3(7):387-9. PubMed ID: 2430751
[TBL] [Abstract][Full Text] [Related]
5. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump.
Tamborlane WV; Sherwin RS; Genel M; Felig P
N Engl J Med; 1979 Mar; 300(11):573-8. PubMed ID: 763270
[TBL] [Abstract][Full Text] [Related]
6. The effect of asymptomatic nocturnal hypoglycemia on glycemic control in diabetes mellitus.
Perriello G; De Feo P; Torlone E; Calcinaro F; Ventura MM; Basta G; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
N Engl J Med; 1988 Nov; 319(19):1233-9. PubMed ID: 3054544
[TBL] [Abstract][Full Text] [Related]
7. Twenty-four hour blood glucose profiles during insulin and insulin plus aprotinin subcutaneous administration in type I diabetes.
Lunetta M; Napoli E; Sudano L; Leonardi R; Mughini L
Horm Metab Res; 1986 Mar; 18(3):182-4. PubMed ID: 2422103
[TBL] [Abstract][Full Text] [Related]
8. Decreased epinephrine responses to hypoglycemia during sleep.
Jones TW; Porter P; Sherwin RS; Davis EA; O'Leary P; Frazer F; Byrne G; Stick S; Tamborlane WV
N Engl J Med; 1998 Jun; 338(23):1657-62. PubMed ID: 9614256
[TBL] [Abstract][Full Text] [Related]
9. Failure of nocturnal hypoglycemia to cause fasting hyperglycemia in patients with insulin-dependent diabetes mellitus.
Tordjman KM; Havlin CE; Levandoski LA; White NH; Santiago JV; Cryer PE
N Engl J Med; 1987 Dec; 317(25):1552-9. PubMed ID: 3317053
[TBL] [Abstract][Full Text] [Related]
10. Aprotinin induced lipohypertrophy and glomerulonephritis in an insulin dependent diabetic.
Dandona P; Mier A; Boag F; Chappell M; Beckett AG
Diabetes Res; 1985 Jul; 2(4):213-6. PubMed ID: 2417774
[TBL] [Abstract][Full Text] [Related]
11. [Insulin-induced edema in adolescents with type 1 diabetes mellitus].
Saule H
Dtsch Med Wochenschr; 1991 Aug; 116(31-32):1191-4. PubMed ID: 1860423
[TBL] [Abstract][Full Text] [Related]
12. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 24-hour insulin requirements in IDDM patients during control by an artificial betacell and during conventional therapy.
Christiansen JS; Svendsen PA; Mathiesen E; Rubin P; Deckert T
Horm Metab Res; 1981 Oct; 13(10):537-41. PubMed ID: 7028586
[TBL] [Abstract][Full Text] [Related]
14. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
15. Control of diabetes through a subcutaneous peritoneal access device (SPAD) in patients with resistance to subcutaneously injected insulin.
Dandona P; Fonseca V; Fernando O; Menon RK; Weerakoon J; Kurtz A; Stephen R
Diabetes Res; 1987 May; 5(1):47-9. PubMed ID: 3304785
[TBL] [Abstract][Full Text] [Related]
16. Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study.
Nimri R; Weintrob N; Benzaquen H; Ofan R; Fayman G; Phillip M
Pediatrics; 2006 Jun; 117(6):2126-31. PubMed ID: 16740856
[TBL] [Abstract][Full Text] [Related]
17. Role of insulin and glucose in the induction of hypoaminoacidemia in man: studies in normal, juvenile diabetic, and insuloma patients.
Adibi SA; Morse EL; Amin PM
J Lab Clin Med; 1975 Sep; 86(3):395-409. PubMed ID: 168278
[TBL] [Abstract][Full Text] [Related]
18. Intensive insulin therapy: Part II. Multicomponent insulin regimens.
Hirsch IB; Herter CD
Am Fam Physician; 1992 Jun; 45(6):2643-8. PubMed ID: 1595513
[TBL] [Abstract][Full Text] [Related]
19. Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels.
Tamborlane WV; Hintz RL; Bergman M; Genel M; Felig P; Sherwin RS
N Engl J Med; 1981 Aug; 305(6):303-7. PubMed ID: 7017416
[TBL] [Abstract][Full Text] [Related]
20. Continuous intravenous insulin therapy with a miniaturized open-loop system.
Renner R; Hepp KD; Mehnert H; Franetzki M
Horm Metab Res Suppl; 1979; (8):186-90. PubMed ID: 395077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
